Similarly, another concluded that the treatment of COVID-19 patients with either arbidol (200 mg t.i.d.), nebulized IFN-α2b (5 mU b.i.d.), or a combination of arbidol plus IFN-α2b. Here, IFNA2 is linked to COVID-19.